MEMORI Corps: Activity-based Companion Care for Dementia (MEMORI Corps)
Primary Purpose
Alzheimer Disease, Dementia
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
MEMORI Corps program
Augmented Waitlist Control
Sponsored by
About this trial
This is an interventional supportive care trial for Alzheimer Disease focused on measuring dementia care, community-based, companion care, activity, caregiver wellbeing, caregiver respite, caregiver support, home-based, volunteer
Eligibility Criteria
Inclusion Criteria:
Persons with dementia and informal caregiver (PWD/CG) must both meet eligibility criteria. These criteria are designed to reduce PWD/CG attrition and ensure safety of PWD, CG, and volunteers.
PWD are eligible if:
- English speaking
- Have an established physician clinical diagnosis of dementia (any stage) and confirmed with the Clinical Dementia Rating Scale of >0.5
- Are able to participate in >2 basic Activities of Daily Living
- Have not received formal (e.g. in-home companion care, or adult day center) respite care services in the past 4 weeks
- Living at home in Baltimore City or Baltimore County.
CGs are eligible if:
- English speaking
- 18 years of age or older (male or female)
- Are deemed to be a reliable informal caregiver (not paid for their care-giving)
- Are co-residing with the PWD
- Are relied on by the PWD for assistance in activities of daily living (instrumental or basic).
Volunteers are eligible if:
- English-speaking
- 55 years or older
- Ability to read
- Ability to pass a criminal background check, drug and physical and mental health screening
- Have reliable transportation and able to travel within 20 miles of home
- A Mini-Mental State Examination score of 24 or above
- Ability to complete the Trail Making Test within specified time limits
- Ability to commit to 12 months of service (10 hours per week excluding travel time)
- Are reliable during intake and on-boarding process.
Exclusion Criteria:
PWD are excluded
- If deemed to be in a crisis/unsafe situation at baseline
- Planned transition from home in less than 6 months
- At end-stage disease (e.g. bed-bound, non-communicative, or hospice)
- Are incontinent of urine or bowels
- Are currently enrolled in a dementia related clinical trial
- Deemed to have severe behavioral symptoms placing self or others at harm.
CGs are excluded if:
- Do not plan to be co-residing with the PWD in the next 6 months
- Are currently involved in a behavioral/educational clinical trial.
Volunteers are excluded:
- Are planning on moving from the area in the next 12 months
- Unable to provide informed consent.
Sites / Locations
- Johns Hopkins UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Active Intervention
Control
Arm Description
Intervention arm with MEMORI Corps program
Augmented waitlist control.
Outcomes
Primary Outcome Measures
Change in neuropsychiatric symptoms as assessed by Neuropsychiatric Inventory (NPI) score
The total score (frequency x severity) of the Neuropsychiatric Inventory (NPI) scale will be used to measure neuropsychiatric and behavioral symptoms. The NPI is a proxy rating of person with dementia's severity, frequency, and distress across 12 types of neuropsychiatric behavior problems. Scores can range from 0-144, with higher score indicating greater neuropsychiatric behavioral burden.
Change in quality of life as assessed by the Quality of life in Alzheimer's Disease (QOL-AD) tool
The total score (sum of all items) for the Quality of life in Alzheimer's Disease (QOL-AD) tool will assess quality of life in the context of Alzheimer's Disease. The QOL-AD has a self-rated and proxy-rated version for persons with dementia, and was specifically developed for use in dementia. Scores can range from 13-52, with higher scores indicating better quality of life.
Change in subjective caregiver burden as assessed by the Zarit Burden Inventory-Short Form
The total score (sum of items) for the Zarit Burden Inventory-Short Form-12 items (ZBI) will assess subjective caregiver burden. The ZBI short form is a self-rated 12-item measure of caregiver subjective burden rating related to caregiving for persons with dementia. Scores can range from 0-48, with higher scores indicating greater perceived burden.
Change in depressive symptoms in caregivers as assessed by The Patient Health Questionnaire (PHQ) - 9
The total score (sum of items) for the The Patient Health Questionnaire (PHQ) - 9 will assess depressive symptoms severity. The PHQ-9 is a self-rated 9 item measure of caregiver depressive symptoms. Scores can range from 0-27, with higher scores indicating greater depressive symptoms.
Change in speed of processing as assessed by the Pattern Comparison test
The total score for the Pattern Comparison test will be used to assess speed of processing changes. The Pattern Comparison test is a neuropsychological test to measure volunteer cognitive speed processing. Higher scores indicate greater speeds of processing.
Change in Gait speed
The time (minutes) it takes subjects to rise from a chair, walk 4 meters, turnaround and sit back down will be used to assess gait speed. This walking speed test to measure volunteer gait disability. Lower time scores indicates better gait functioning.
Change in executive functioning as assessed by Trail Making Test B
The score for the Trail Making Test B will be used to measure volunteer executive functioning. Lower time score indicates better executive functioning.
Change in activity engagement as assessed by the Community Healthy Activities Model Program for Seniors activity questionnaire
The total score from the Community Healthy Activities Model Program for Seniors activity questionnaire will be used to quantify engagement in various forms of activities over the course of a week. Scores can range from 0-168, with higher scores indicating greater activity engagement.
Secondary Outcome Measures
Change in outpatient health services use as assessed by the Resource Utilization in Dementia/Services Utilization and Resources Survey
This is a proxy rated measure (Resource Utilization in Dementia/Services Utilization and Resources Survey; SURFS) of family caregiver outpatient medical services. Total scores are for each category and represent counts of service type encounters (range 0-90) for outpatient medical services, with higher counts indicating more service type utilization.
Change in home and community-based long term services and supports use health services use as assessed by the Resource Utilization in Dementia/Services Utilization and Resources Survey
Community based long term services and supports is summarized by count of service type category, ranging from 0-12, with higher counts indicating more service category utilization.
Change in objective caregiver burden as assessed by time estimates in performing tasks
Two individual items ask caregivers to estimate hours per day spent doing caregiving activities, and hours per day spent with the person with dementia in a typical week. Objective measure of caregiver burden. Higher time estimates in performing these tasks indicate greater objective burden.
Change in stress as assessed by the Elders Life Stress Inventory
The investigators will use a total score of the Elders Life Stress Inventory to measure stress ratings by volunteers. The total score ranges from 0-31 and indicates the total sum of 31 different types of stressful life events over the observation period related to several domains of the persons life. Higher counts of stressful events represent greater stress.
Time to transition from home
The investigators will record the time (days) from randomization to transition from home using survival analyses. These exploratory analyses will estimate risk of all-cause transition out of home for person with dementia
Change in depressive symptoms in senior companion volunteers as assessed by The Patient Health Questionnaire (PHQ) - 9
The total score (sum of items) for the The Patient Health Questionnaire (PHQ) - 9 will assess depressive symptoms severity in senior companion volunteers. The PHQ-9 is a self-rated 9 item measure of caregiver depressive symptoms. Scores can range from 0-27, with higher scores indicating greater depressive symptoms.
Full Information
NCT ID
NCT03896711
First Posted
March 28, 2019
Last Updated
June 23, 2023
Sponsor
Johns Hopkins University
Collaborators
Alzheimer's Association, National Institute on Aging (NIA)
1. Study Identification
Unique Protocol Identification Number
NCT03896711
Brief Title
MEMORI Corps: Activity-based Companion Care for Dementia
Acronym
MEMORI Corps
Official Title
MEMORI Corps: A Novel Activity-based Companion Care Program to Benefit Community-living Persons With Dementia, Their Families, and Senior Volunteers
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
September 29, 2024 (Anticipated)
Study Completion Date
September 29, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
Alzheimer's Association, National Institute on Aging (NIA)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a single blind, intention-to-treat, randomized controlled trial design to evaluate the feasibility and efficacy of a 12-week, evidence-based, individualized MEMORI Corps program delivered by trained older volunteers (n=80) to community-living PWD/CG dyads (n=240). Eligible PWD/CG dyads will be randomized to receive 12-weeks intervention group (n=120), or 12-week augmented waitlist control group (n=120) followed by 12-weeks of intervention. Eligible volunteers will be randomized to 12 months of MEMORI Corps active duty (n=40) where the participants will be matched to three families over the course of a year, or a 12-month augmented waitlist control group (n=40) followed by opportunity to serve 12 months active duty in MEMORI Corps. Program goals are to address unmet respite care needs for family caregivers, provide persons with dementia meaningful evidence-based activity programming, as well as provide health benefits, meaningful productive engagement, and peer support opportunities for senior volunteers.
Detailed Description
In partnership with the Alzheimer's Association, the investigators propose to evaluate in a NIH Stage III (Real World Efficacy) randomized trial, Making Engagement Meaningful through Organized Routine Interaction (MEMORI) Corps, a novel 12-week activity-based companion care model, to mobilize and equip a critical mass of senior volunteers to deliver individualized, evidence-based activity programming to PWD living at home and offer family CGs needed respite. Synthesizing and adapting prior evidence-based work from the Tailored Activities Program® (a proven activity-based intervention to address functional decline and behavioral symptoms in persons with dementia), Experience Corps® (an inter-generational civic engagement program that engages senior volunteers to work in elementary schools to improve academic outcomes for children and improve health outcomes for the volunteers), and MIND at Home® (a home-based dementia care coordination program delivered by non-clinical care coordinators supported by a clinical team), MEMORI Corps takes a social model of health approach to simultaneously address unmet respite care needs of family CGs, provide PWD structured meaningful activities and social engagement, and provide meaningful engagement and peer support opportunities for senior volunteers-creating potential for a "win-win-win" scenario.
This single blind, two-arm, randomized controlled trial will evaluate the feasibility and efficacy of a 12-week, evidence-based, individualized MEMORI Corps program delivered by trained senior volunteers (n=80) to community-living PWD and participant's family caregivers (n=240 dyads). Core intervention components include: (1) detailed initial home-based assessment of interests and preserved abilities of PWD; (2) individualized activity program plans based on interests and abilities; (3) training of volunteers in communication and simplification strategies and use of activity program plans; (4) delivery of activity plans by volunteers to PWD over 12 weeks (8 hours/week) in participant's homes; (5) family CG education on activity plans and ways to utilize respite opportunities; and (6) support of volunteers from a skilled multidisciplinary clinical team. PWD/CG outcomes will be assessed at baseline, 6-, and 12-weeks. Volunteer outcomes will be assessed at baseline, 6- and 12-months (volunteer participation lasts 12 months).
Specific aims are to evaluate the:
Aim 1: Efficacy of the MEMORI Corps intervention on community-living PWD quality of life and neuropsychiatric symptoms at 6- and 12-weeks (primary endpoint) versus augmented wait-list control.
Aim 2: Efficacy of MEMORI Corps intervention on CG subjective and objective burden and depressive symptoms at 6- and 12-weeks (primary endpoint) versus augmented wait-list control.
Aim 3: Efficacy of MEMORI Corps intervention on volunteer physical function, cognition, and social and psychological engagement at 6-months and 12-months (primary endpoint) versus augmented wait-list control.
Aim 4: Acceptability and feasibility of implementing the MEMORI Corps program from various stakeholder perspectives (PWD, informal CGs, senior volunteers, volunteer coordinators/supervisors).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease, Dementia
Keywords
dementia care, community-based, companion care, activity, caregiver wellbeing, caregiver respite, caregiver support, home-based, volunteer
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Activity-based companion care program. Delivered by trained senior volunteers, supported by a clinical team, over a 12-week intervention period (8 hours per week, 2 or 3 days per week) for each person with dementia/family caregiver dyad. Primary roles of the volunteers are to provide in-home supervision, peer-to-peer companionship, and a evidence-based individualized activity program that focuses on meaningful, engaging and enjoyable activities that match PWD abilities and interests.
Masking
Outcomes Assessor
Masking Description
Single blind randomized controlled trial where outcome assessors are masked to treatment arm allocation.
Allocation
Randomized
Enrollment
560 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Active Intervention
Arm Type
Experimental
Arm Description
Intervention arm with MEMORI Corps program
Arm Title
Control
Arm Type
Other
Arm Description
Augmented waitlist control.
Intervention Type
Behavioral
Intervention Name(s)
MEMORI Corps program
Intervention Description
Activity-based companion care program. Delivered by trained senior volunteers, supported by a clinical team, over a 12-week intervention period (8 hours per week, 2 or 3 days per week) for each person with dementia/family caregiver dyad. Primary roles of the volunteers are to provide in-home supervision, peer-to-peer companionship, and a evidence-based individualized activity program that focuses on meaningful, engaging and enjoyable activities that match PWD abilities and interests.
Intervention Type
Other
Intervention Name(s)
Augmented Waitlist Control
Intervention Description
Persons with dementia/caregivers will continue any services and supports being used, will receive a free copy of "A Caregiver's Guide to Dementia: Using Activities and Other Strategies to Prevent, Reduce and Manage Behavioral Symptom"103), written educational materials on management of CG stress/well-being, and bi-weekly check-in calls to answer any questions about the materials. Volunteers randomized to waitlist control will continue with usual activities (volunteer or other), and will receive additional written educational materials on cognitive health (NIA) and exercise and Physical Activity (Go4Life), referrals to the Baltimore City Commission on Aging and Retirement Education for volunteering opportunities, and bi-monthly check-in calls to answer questions and maintain engagement. Waitlist dyads will be followed at specified intervals by the research team and then offered an opportunity for participation in the intervention arm.
Primary Outcome Measure Information:
Title
Change in neuropsychiatric symptoms as assessed by Neuropsychiatric Inventory (NPI) score
Description
The total score (frequency x severity) of the Neuropsychiatric Inventory (NPI) scale will be used to measure neuropsychiatric and behavioral symptoms. The NPI is a proxy rating of person with dementia's severity, frequency, and distress across 12 types of neuropsychiatric behavior problems. Scores can range from 0-144, with higher score indicating greater neuropsychiatric behavioral burden.
Time Frame
Baseline to 12 weeks
Title
Change in quality of life as assessed by the Quality of life in Alzheimer's Disease (QOL-AD) tool
Description
The total score (sum of all items) for the Quality of life in Alzheimer's Disease (QOL-AD) tool will assess quality of life in the context of Alzheimer's Disease. The QOL-AD has a self-rated and proxy-rated version for persons with dementia, and was specifically developed for use in dementia. Scores can range from 13-52, with higher scores indicating better quality of life.
Time Frame
Baseline to 12 weeks
Title
Change in subjective caregiver burden as assessed by the Zarit Burden Inventory-Short Form
Description
The total score (sum of items) for the Zarit Burden Inventory-Short Form-12 items (ZBI) will assess subjective caregiver burden. The ZBI short form is a self-rated 12-item measure of caregiver subjective burden rating related to caregiving for persons with dementia. Scores can range from 0-48, with higher scores indicating greater perceived burden.
Time Frame
Baseline to 12 weeks
Title
Change in depressive symptoms in caregivers as assessed by The Patient Health Questionnaire (PHQ) - 9
Description
The total score (sum of items) for the The Patient Health Questionnaire (PHQ) - 9 will assess depressive symptoms severity. The PHQ-9 is a self-rated 9 item measure of caregiver depressive symptoms. Scores can range from 0-27, with higher scores indicating greater depressive symptoms.
Time Frame
Baseline to 12 weeks
Title
Change in speed of processing as assessed by the Pattern Comparison test
Description
The total score for the Pattern Comparison test will be used to assess speed of processing changes. The Pattern Comparison test is a neuropsychological test to measure volunteer cognitive speed processing. Higher scores indicate greater speeds of processing.
Time Frame
Baseline to 12 weeks
Title
Change in Gait speed
Description
The time (minutes) it takes subjects to rise from a chair, walk 4 meters, turnaround and sit back down will be used to assess gait speed. This walking speed test to measure volunteer gait disability. Lower time scores indicates better gait functioning.
Time Frame
Baseline to 12 weeks
Title
Change in executive functioning as assessed by Trail Making Test B
Description
The score for the Trail Making Test B will be used to measure volunteer executive functioning. Lower time score indicates better executive functioning.
Time Frame
Baseline to 12 weeks
Title
Change in activity engagement as assessed by the Community Healthy Activities Model Program for Seniors activity questionnaire
Description
The total score from the Community Healthy Activities Model Program for Seniors activity questionnaire will be used to quantify engagement in various forms of activities over the course of a week. Scores can range from 0-168, with higher scores indicating greater activity engagement.
Time Frame
Baseline to 12 weeks
Secondary Outcome Measure Information:
Title
Change in outpatient health services use as assessed by the Resource Utilization in Dementia/Services Utilization and Resources Survey
Description
This is a proxy rated measure (Resource Utilization in Dementia/Services Utilization and Resources Survey; SURFS) of family caregiver outpatient medical services. Total scores are for each category and represent counts of service type encounters (range 0-90) for outpatient medical services, with higher counts indicating more service type utilization.
Time Frame
Baseline to 12 weeks
Title
Change in home and community-based long term services and supports use health services use as assessed by the Resource Utilization in Dementia/Services Utilization and Resources Survey
Description
Community based long term services and supports is summarized by count of service type category, ranging from 0-12, with higher counts indicating more service category utilization.
Time Frame
Baseline to 12 weeks
Title
Change in objective caregiver burden as assessed by time estimates in performing tasks
Description
Two individual items ask caregivers to estimate hours per day spent doing caregiving activities, and hours per day spent with the person with dementia in a typical week. Objective measure of caregiver burden. Higher time estimates in performing these tasks indicate greater objective burden.
Time Frame
Baseline to 12 weeks
Title
Change in stress as assessed by the Elders Life Stress Inventory
Description
The investigators will use a total score of the Elders Life Stress Inventory to measure stress ratings by volunteers. The total score ranges from 0-31 and indicates the total sum of 31 different types of stressful life events over the observation period related to several domains of the persons life. Higher counts of stressful events represent greater stress.
Time Frame
Baseline to 12 weeks
Title
Time to transition from home
Description
The investigators will record the time (days) from randomization to transition from home using survival analyses. These exploratory analyses will estimate risk of all-cause transition out of home for person with dementia
Time Frame
Baseline to 12 weeks
Title
Change in depressive symptoms in senior companion volunteers as assessed by The Patient Health Questionnaire (PHQ) - 9
Description
The total score (sum of items) for the The Patient Health Questionnaire (PHQ) - 9 will assess depressive symptoms severity in senior companion volunteers. The PHQ-9 is a self-rated 9 item measure of caregiver depressive symptoms. Scores can range from 0-27, with higher scores indicating greater depressive symptoms.
Time Frame
Baseline to 12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
115 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Persons with dementia and informal caregiver (PWD/CG) must both meet eligibility criteria. These criteria are designed to reduce PWD/CG attrition and ensure safety of PWD, CG, and volunteers.
PWD are eligible if:
English speaking
Have an established physician clinical diagnosis of dementia (any stage) and confirmed with the Clinical Dementia Rating Scale of >0.5
Are able to participate in >2 basic Activities of Daily Living
Have not received formal (e.g. in-home companion care, or adult day center) respite care services in the past 4 weeks
Living at home in Baltimore City or Baltimore County.
CGs are eligible if:
English speaking
18 years of age or older (male or female)
Are deemed to be a reliable informal caregiver (not paid for their care-giving)
Are co-residing with the PWD
Are relied on by the PWD for assistance in activities of daily living (instrumental or basic).
Volunteers are eligible if:
English-speaking
55 years or older
Ability to read
Ability to pass a criminal background check, drug and physical and mental health screening
Have reliable transportation and able to travel within 20 miles of home
A Mini-Mental State Examination score of 24 or above
Ability to complete the Trail Making Test within specified time limits
Ability to commit to 12 months of service (10 hours per week excluding travel time)
Are reliable during intake and on-boarding process.
Exclusion Criteria:
PWD are excluded
If deemed to be in a crisis/unsafe situation at baseline
Planned transition from home in less than 6 months
At end-stage disease (e.g. bed-bound, non-communicative, or hospice)
Are incontinent of urine or bowels
Are currently enrolled in a dementia related clinical trial
Deemed to have severe behavioral symptoms placing self or others at harm.
CGs are excluded if:
Do not plan to be co-residing with the PWD in the next 6 months
Are currently involved in a behavioral/educational clinical trial.
Volunteers are excluded:
Are planning on moving from the area in the next 12 months
Unable to provide informed consent.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Quincy Samus, PhD
Phone
4105506493
Email
qmiles@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Melissa Reuland, MS
Phone
410-550-6477
Email
mreulan1@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Quincy Samus, PhD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins University
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Morgan Spliedt, MS
Phone
410-550-6744
Email
memoricorps@jhmi.edu
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Results and learning from this Phase III randomized controlled trial (RCT) will be strategically disseminated to a variety of stakeholders (persons with dementia, family caregivers, partners, advocacy organizations, volunteer organizations, community-based organizations, state and federal policy makers, regulators, health and supportive care services providers, health organizations and health system decision makers) and in a variety of formats (peer reviewed publications, professional and scientific conferences, community lectures, popular press articles, briefs, blog posts). Messaging will be specifically tailored to stakeholder groups to support the effective communication of the science and key findings.
Learn more about this trial
MEMORI Corps: Activity-based Companion Care for Dementia
We'll reach out to this number within 24 hrs